Status:
RECRUITING
Automated Insulin for Management of Intrapartum Glycemia
Lead Sponsor:
University of California, San Francisco
Conditions:
Type 1 Diabetes (T1D)
Pregnancy
Eligibility:
FEMALE
13-55 years
Phase:
NA
Brief Summary
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main q...
Eligibility Criteria
Inclusion
- Known diagnosis of type 1 diabetes ≥ 1 year
- Current use of commercially available AID system ≥ 6 months
- Currently pregnant at ≥ 34 weeks
- Singleton pregnancy
- English- or Spanish-speaking
Exclusion
- Planned cesarean delivery
- Use of medications known to interfere with glucose metabolism
- Intrauterine fetal demise
- Physical or psychological disease likely to interfere with the conduct of the study and/or the ability to participate in own healthcare
Key Trial Info
Start Date :
December 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06883344
Start Date
December 5 2025
End Date
December 31 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143